Induced Pluripotent Stem Cells: A U.S. Patent Landscape Analysis

14 May 2013 Genetic Engineering and Biotechnology News Publication
Authors: Antoinette F. Konski

Genetic Engineering and Biotechnology News

Partner Antoinette Konski and Associate Simon Elliott authored, “Induced Pluripotent Stem Cells: A U.S. Patent Landscape Analysis,” published in the May 14, 2013 edition of Genetic Engineering and Biotechnology News. The article provides a discussion of the U.S. patent landscape for induced pluripotent stem cells (iPSCs) and identifies key technologies and institutions that are leading research and development in the creation and use of iPSCs.

The article also was referenced in a May 14, 2013 piece in the Boston Business Journal, which discussed the growth in the number of iPSCs patents held by Cambridge-area companies.

Click here to read the entire article. 

Related Services

Insights

Bad Holiday Season News! Estimates of an increase of Cyberattacks 20%!
13 December 2019
Internet, IT & e-Discovery Blog
Driving the Future of Automotive Technology
12 December 2019
Manufacturing Industry Advisor
Massachusetts Governor Proposes Facility Fee Ban
12 December 2019
Health Care Law Today
American Rule Prevails; PTO May Not Collect In-House Attorneys' Fees as "Expenses"
12 December 2019
IP Litigation Current
ACCC 46th Annual Meeting & Cancer Center Business Summit
04-05 March 2020
Washington, D.C.
Foley/Deloitte Compliance and Privacy Officer Roundtable
27 February 2020
Boston, MA
Let’s Talk Compliance
24 January 2020
Orlando, FL
New England Alliance Annual Meeting
15-17 January 2020
Woodstock, VT